Celltrion Healthcare’s Zymfentra Set for U.S. Launch in February
Seoul - Celltrion Healthcare Co. announced Thursday that its new autoimmune disease treatment, Zymfentra, is scheduled to hit the U.S. market on February 29 next year. Zymfentra, a subcutaneous injection…